COMMUNIQUÉS West-GlobeNewswire

-
NANOBIOTIX : THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NANOBIOTIX HAVE AN AGREEMENT TO RUN IMMUNOTHERAPEUTIC PRE-CLINICAL RESEARCH IN LUNG CANCER COMBINING NBTXR3 AND NIVOLUMAB
10/04/2018 -
NANOBIOTIX : NANOBIOTIX ET L'UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER LANCENT UN PROJET DE RECHERCHE PRÉCLINIQUE EN IMMUNOTHÉRAPIE COMBINANT NBTXR3 ET NIVOLUMAB DANS LE CANCER DU POUMON
10/04/2018 -
NeuroMetrix Reports Results of Large Clinical Study of Quell Wearable Pain Relief
10/04/2018 -
Bee Prepared: How to Treat a Bee Sting -- American Academy of Dermatology
10/04/2018 -
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
10/04/2018 -
S. Parikh Mars, CEO of Progressive Care Returns to Uptick Newswire’s "Stock Day" Podcast with Everett Jolly
10/04/2018 -
Scythian Biosciences Announces Details of 4-for-1 Stock Split
10/04/2018 -
Dennis Shin, Former Advisory Board Executive, Joins Syapse as Chief Commercial Officer
10/04/2018 -
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Discusses Strong Finish to 2017 and Operational Developments for 2018 on Uptick Newswire’s “Stock Day” Podcast with Everett Jolly
10/04/2018 -
Stealth Mark Announced as ICTA Anti-Counterfeiting Task Force New Appointee to Research Work Group
10/04/2018 -
Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval
10/04/2018 -
Central Ohio Urology Group Partners with HIFU Prostate Services to Offer Non-Invasive HIFU Treatment for Localized Prostate Cancer
10/04/2018 -
New Online Commentary in UroToday on Fexapotide BPH Clinical Trial Results Publication in World Journal of Urology
10/04/2018 -
Passing of Genmab A/S’ Annual General Meeting
10/04/2018 -
Vericel to Present at the 6th Annual Cell & Gene Therapy Investor Day
10/04/2018 -
AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy in Patients with X-linked Retinoschisis (XLRS)
10/04/2018 -
ProLynx announces allowance of additional U.S. patent for PLX038, a novel DNA damage response enhancer
10/04/2018 -
Patient Home Monitoring Announces Plans to Change Name to Protech Home Medical; Launches New Investor Website
10/04/2018 -
Loop Industries Appoints Laurence Sellyn to Board of Directors
10/04/2018
Pages